METAvivor Receives $50,000 Grant from Avon-Pfizer

Supporting and Educating Metastatic Breast Cancer Patients

The program Identify-Amplify-Unify, run by Pfizer Inc. and the Avon Foundation for Women, has granted a total of $1 million to 23 organizations nationwide to support and educate metastatic breast cancer patients, their caregivers, and their communities. METAvivor was chosen as one of those recipients. The METAvivor grant will be used to enhance patient support and increase public understanding of the disease.